Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
CATALYST PHARMACEUTICALS, INC. (CPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in CATALYST PHARMACEUTICALS, INC. |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 5.6% stake in Catalyst Pharmaceuticals, Inc. |
| 02/08/2023 |
SC 13G/A
| STATE STREET CORP reports a 7.6% stake in AMEMDED FILING CATALYST PHARMACEUTICALS INC |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 15.1% stake in CATALYST PHARMACEUTICALS INC |
| 01/20/2023 |
SC 13G/A
| BlackRock Inc. reports a 15.1% stake in CATALYST PHARMACEUTICALS INC |
| 10/07/2022 |
SC 13G/A
| BlackRock Inc. reports a 14.9% stake in CATALYST PHARMACEUTICALS INC |
| 02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 9.3% stake in Catalyst Pharmaceuticals, Inc. |
| 02/09/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 4.7% stake in Catalyst Pharmaceuticals Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 9.7% stake in Catalyst Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Catalyst Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Catalyst Pharmaceuticals, Inc. |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8.2% stake in CATALYST PHARMACEUTICALS INC |
| 01/09/2020 |
SC 13G/A
| Consonance Capital Management LP reports a 0% stake in CATALYST PHARMACEUTICALS, INC |
| 12/09/2019 |
SC 13G/A
| Consonance Capital Management LP reports a 5% stake in CATALYST PHARMACEUTICALS, INC |
| 03/06/2019 |
SC 13G/A
| Consonance Capital Management LP reports a 12.9% stake in CATALYST PHARMACEUTICALS, INC |
| 02/13/2019 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 2.8% stake in Catalyst Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G/A
| Broadfin Capital, LLC reports a 6.1% stake in Catalyst Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 5.7% stake in Catalyst Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2017 |
SC 13G/A
| Broadfin Capital, LLC reports a 9.9% stake in Catalyst Pharmaceuticals, Inc. |
| 05/09/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2016 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.7% stake in CATALYST PHARMACEUTICALS, INC. |
| 02/12/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/01/2012 |
SC 13G/A
| SOPHROSYNE CAPITAL LLC reports a 4.7% stake in Catalyst Pharmaceutical Partners, Inc. |
| 08/28/2012 |
SC 13G/A
| SOPHROSYNE CAPITAL LLC reports a 6.5% stake in Catalyst Pharmaceutical Partners, Inc. |
| 02/14/2012 |
SC 13G/A
| CATALYST PHARMACEUTICAL PARTNERS, INC. reports a 7.9% stake in CATALYST PHARMA PARTNERS INC |
| 02/09/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2011 |
SC 13G/A
| Catalyst Pharmaceutical Partners, Inc. reports a 12.8% stake in CATALYST PHARMACEUTICAL PARTNERS, INC. |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2010 |
SC 13G/A
| Catalyst Pharmaceutical Partners, Inc. reports a 13.8% stake in CATALYST PHARMACEUTICAL PARTNERS, INC. |
|
|
|